Covid-19 Antibody Seroprevalence in Santa Clara County, California
medrxiv.org
medrxiv.org
"This study had several limitations. First, our sampling strategy selected for members of Santa Clara County with access to Facebook and a car to attend drive-through testing sites. This resulted in an over-representation of white women between the ages of 19 and 64, and an under-representation of Hispanic and Asian populations, relative to our community. Those imbalances were partly addressed by weighting our sample population by zip code, race, and sex to match the county. We did not account for age imbalance in our sample, and could not ascertain representativeness of SARS-CoV-2 antibodies in homeless populations. Other biases, such as bias favoring individuals in good health capable of attending our testing sites, or bias favoring those with prior COVID-like illnesses seeking antibody confirmation are also possible. The overall effect of such biases is hard to ascertain."
What you see is that certain groups were less likely to go get tested, UNLESS they had a good reason to think that they were positive. This should cause them to want to underweight the data from the underrepresented groups, but instead they overweighted it.
You can almost say that there were two populations that they were testing: White women who lived near a testing site who thought "what the hell, I'm bored with this quarantine so might as well get my finger pricked", and people who thought "I wonder if that thing I had a few weeks ago was COVID." The number you want is the prevalence from the bored white women. Bored white women might be somewhat skewed from other demographics, but probably not by that much. People who thought they might have had it is a massively skewed group. Effectively their correction removes the bored white women near a testing site, and only counts the people who have reason to think they had COVID.
I think it's understood, that with such a small sample size, results are to be taken cautiously. You have to start somewhere though.
Castiglione d'Adda has more people over 70 than Santa Clara County has over 65; population over 65 is about 60% higher relatively. Population under 18 conversely is about 22% lower.
Hard to do the math exactly, but if you simply switch 8.1% of your population from being children to being 80+, you raise IFR by 0.6% per the Imperial College China estimates. Combined with the hospital triaging Italy was doing, I don't think sub-1% IFRs in Santa Clara county are improbable. (though I do think this survey's claims are improbably low)
sources: https://www.citypopulation.de/php/italy-localities-lombardia...
https://www.census.gov/quickfacts/santaclaracountycalifornia
https://www.thelancet.com/journals/laninf/article/PIIS1473-3...
Santa Clara county though is one of the healthiest places in the US. Life expectancy of 84 exceeds Italy in fact.
Your entire argument boils down to “I don’t like the implications of their adjustment, and this other one would have produced results more consistent with my theories.”
The point is that the higher your (voluntary) participation rate is within a group, the less chance you have of selection bias. This goes up to the limit of 100% participation, where you have no selection bias.
What we see in this study is that groups with a lower participation rate (Men, nonwhites, people farther from a testing site) have a higher positivity rate. That is exactly the selection bias we would expect. They then proceed to "correct" the data by undercounting the group (white women that live near a testing site) that has the least selection bias.
The demographics of a tested population do not match the demographics of the county.
If someone believes they've been infected they are more likely to seek testing. (self-selection bias)
The study adjusted for the first but not the second bias. He believes the second bias is more important, so when they adjusted for the first they moved the adjusted average farther away from the true average.
I think he's right, self-selection can be a far more impactful bias than things like sex and race.
On the other hand, it's hard to reconcile their finding with anything less than 90% or more of infections being missing from the case count. And 10% of the infection fatality rate is really exciting news. It also means that it's exceptionally likely that jurisdictions like New York are a huge slice of the way (15% of population infected?) to herd immunity.
The only problem is that to get the other half way there, another 20,000 people have to die, just in New York City. That doesn't even count the already existing infections that haven't died yet.
https://www.nejm.org/doi/full/10.1056/NEJMc2009316
> Between March 22 and April 4, 2020, a total of 215 pregnant women delivered infants at the New York–Presbyterian Allen Hospital and Columbia University Irving Medical Center . All the women were screened on admission for symptoms of Covid-19. Four women (1.9%) had fever or other symptoms of Covid-19 on admission, and all 4 women tested positive for SARS-CoV-2 (Figure 1). Of the 211 women without symptoms, all were afebrile on admission. Nasopharyngeal swabs were obtained from 210 of the 211 women (99.5%) who did not have symptoms of Covid-19; of these women, 29 (13.7%) were positive for SARS-CoV-2. Thus, 29 of the 33 patients who were positive for SARS-CoV-2 at admission (87.9%) had no symptoms of Covid-19 at presentation.
Pregnant women would seem to be much less able to avoid certain activities that involve transmission (like visiting medical facilities and associated close contact with people who also work in hospitals with inadequate and improvised PPE), so that’s probably not a great assumption.
Santa Clara county only being 15% as infected is not consistent.
There is an unknown quality about New York that causes the virus to be 4 times more severe.
A self-selected group from the internet demonstrated self-selection sampling bias.
I know where I would put my money.
We can quibble a whole lot with exact effect magnitudes and data analysis techniques, but...
In any case, we have a whole lot of data (Iceland RTPCR, Gangelt RTPCR, Switzerland RTPCR, Netherlands blood donation serology, Santa Clara County serology) that indicates infection rates likely exceed case rates by 10x or more in areas with relatively good testing availability.
I wonder if these ads mentioned the purpose of the study, or if that information was only given out after initial contact (I don't know enough about IRB requirements here).
A concern is that this could cause a selection bias for people who suspected they had the virus. People may respond to such an ad out of curiosity ("I think I had the virus, so it would be good to know for sure") or obligation ("I'm pretty sure I had the virus, so I should help out with this study").
It wouldn't have to be a large selection bias, either. Of the 3,330 people they tested, they found only 50 who tested positive.
I would like to see a bit of a better method of sample selection before drawing any conclusions.
"We used Facebook to quickly reach a large number of county residents and because it allows for granular targeting by zip code and sociodemographic characteristics. We used a combination of two targeting strategies: ads aimed at a representative population of the county by zip code, and specially targeted ads to balance our sample for under-represented zip codes. In addition, we capped registrations from overrepresented areas."
Update: Okay, "Other biases, such as bias favoring individuals in good health capable of attending our testing sites, or bias favoring those with prior COVID-like illnesses seeking antibody confirmation are also possible."
"This study had several limitations. First, our sampling strategy selected for members of Santa Clara County with access to Facebook and a car to attend drive-through testing sites. This resulted in an overrepresentation of white women between the ages of 19 and 64, and an under-representation of Hispanic and Asian populations, relative to our community. Those imbalances were partly addressed by weighting our sample population by zip code, race, and sex to match the county. We did not account for age imbalance in our sample, and could not ascertain representativeness of SARS-CoV-2 antibodies in homeless populations. Other biases, such as bias favoring individuals in good health capable of attending our testing sites, or bias favoring those with prior COVID-like illnesses seeking antibody confirmation are also possible. The overall effect of such biases is hard to ascertain."
Of course there is selection bias, which is why they make adjustments to make the sample better represent the population (see the abstract for details on this, or read the paper for all the details, there's well-established science behind these adjustments and it's up to the reviewers to be sure that they did it correctly). The point is that "they only found 50" is quite a large number compared to the number of confirmed cases.
They describe their limitations and adjustments exactly like most other studies of this sort do. For example:
"Those imbalances were partly addressed by weighting our sample population by zip code, race, and sex to match the county. "
Given that, I think it's fair to say that they have not adjusted for the selection bias of people with prior clinical symptoms being more likely to click the ad.
Many studies are only as good as their sampling methods. A good sampling method will alleviate concerns of selection bias.
But I also agree they 100% did not do any of these adjustments if they did it would be listed right here
> We report the prevalence of antibodies to SARS-CoV-2 in a sample of 3,330 people, adjusting for zip code, sex, and race/ethnicity. We also adjust for test performance characteristics using 3 different estimates: (i) the test manufacturer's data, (ii) a sample of 37 positive and 30 negative controls tested at Stanford, and (iii) a combination of both.
I wonder why this is so vastly different from the study above.
https://en.wikipedia.org/wiki/2020_coronavirus_pandemic_in_I...
This is only a small comfort since it means we may have had about 8.75 million infected and presumably now immune in the USA. Or about 2.6%. There’s still a long way to go in that case.
Yes and no.
A disease is endemic when R0 x S = 1 [0]. R0 for SARS-CoV-2 is estimated to be 2.5 to 3.5 and some models predicting a much higher 5.7 [1].
The herd immunity threshold is given by (1 - S)%, which implies when R0 = 2.5, 60% of the population would need to be immune; similarly 71.42% and 82.45% for R0s, 3.5 and 5.7, respectively.
I believe the SIR model [0] answers those questions. 3blue1brown's video on the topic is super digestible and informative [1].
In short, the discovery of a prophylactic if not a therapeutic treatment are our best immediate bets, absent which, quarantines and lockdowns will have to persist to curb the spread of a disease as infectious as covid-19 whilst we patiently wait for an effective vaccine against it [2].
[0] https://en.wikipedia.org/wiki/Compartmental_models_in_epidem...
Really want to get a test on myself and family. We had something that near hospitalized me, but the kids barely registered being sick.
[Edit: 'No symptoms experienced at time of positive test results' is intended to mean the same as 'no symptoms experienced yet at time of positive test results'.]
Like, it was for a while impossible to get a test if you are not experiencing multiple symptoms AND can make a case that you might have been exposed via interacting with someone who has traveled. Even now I don't think they're giving the test if you don't have a fever. It's implausible that 50% of the people tested by the official pathway had no symptoms because the official pathway is not available when you have no symptoms.
But if you mean that you've seen a 50% "asymptomatic transmission" rate, in other words studies like this that purport to test a bunch of people at random and see how many of them have COVID-19, note that this definition of "asymptomatic" may include many with symptoms not severe enough to be hospitalized -- in other words they might have been feverish and coughing but not moreso than a typical cold. I myself have had a really nasty cough but it is not "dry" but "productive" and it has not come with a fever -- I would really love to be tested but right now that does not seem to be possible! Maybe I am in this above grouping of "asymptomatic" folks.
The OP article suggests that as many as 98-99% of cases might not involve hospitalization and therefore might be cases like mine (assuming I do indeed have COVID-19, maybe I don't). Now it is likely that there is some sort of selection bias in how they recruited candidates, but still it tends to push that number above your high end of 70%, suggesting maybe it's closer to 80 or 90%. On the other hand while the paper says that it did its due diligence subtracting out the test's false-positive rate, a rather small error here can have a big impact on that number because there are so few true positives right now.
In some ways the paper's claim is a bit of good news, it means that this disease has much lower mortality than we were originally told. (There may be lower bounds on mortality -- I have heard of one town in Italy where 1% of its population is gone due to COVID-19 in which case that would seem to be a good lower bound.) In other ways it is bad news, it means that this disease, still with nontrivial mortality, is going to be much less affected by quarantine countermeasures and the social distancing stuff is really the only reason it is spreading as slowly as it is, so that we need to endure the pain of isolation for much longer -- potentially until testing becomes widespread and cheap.
That may not be too much longer, as mentioned in a previous HN comment/story [1] that if you can get testing to work with the old Sanger sequencers used in the Human Genome Project you can maybe ramp up to 200,000 samples/day at first with possibilities to go up to 1M/day once you solve additional logistical problems. Before that the production of kits and sourcing of reagents may be your limit.
An example where testing was conducted without requiring symptoms first: https://taskandpurpose.com/news/uss-theodore-roosevelt-sailo...
If it's the nasal swab-PCR test that most civilians are getting, then the claim of "asymptomatic" must be accompanied by a "yet". We can't really conclude anything for at least two weeks after the positive result -- after seeing whether those people ever develop symptoms.
If it's blood-antibody testing, then we can give the statement a little more weight, because a positive result would mean the infection is in a later stage or even past. I have no idea whether the Navy is using these tests.
This is in the bay area, where people were very quick to self-quarantine. Most people have been working from home since early March. They were asking people to break their self-quarantine to get tested without having any symptoms?
Highly unlikely these are all just people who have produced antibodies as part of a yet-to-be overrun immune response.
https://www.thelancet.com/journals/laninf/article/PIIS1473-3...
I would be surprised if, after this current wave of infections, the percentage of people with antibodies in the US is higher than the low single digits.
Herd immunity without a vaccine is a pipe dream. Our best bet is to massively ramp up testing and contact tracing and really start pushing the number of infections down to a point where parts of society can start functioning again.
Total Covid deaths are already at a "mild flu season" level already after a month and continuing some level of exponential growth after social distancing.
It's sad and awful but it seems like with the current administration approach, the response of ramped up contract tracing has pretty much flown away and with these figures, we're looking 500K deaths, 250K over the next two month and another 250K over a longer period. Hide your parents...
NYC, for example, has 123k confirmed cases. Multiply by 50, and you have 6.1M, which is close to 70% of the total population.
You should read it before commenting.
In the Netherlands a fatality rate of 0.5% would mean it'd take about a year for herd immunity to kick in assuming we managed sustain the peak that occurred about 2 weeks ago (and it's somewhat dubious whether the healthcare system actually can sustain that peak).
328.2 million (Approximate population of the US [1]) * 80% for herd immunity (based on an R0 5.7 [2]) * 1% = 2.6 million people die.
If the fatality rate is 0.5% instead, then 1.3 million people die If the fatality rate is 0.1%, we're still looking at ~260k-ish people.
That's pretty grim.
This situation is still developing so hopefully those numbers get adjusted downwards as later information becomes available.
For reference, ~1.2 million people died to heart attacks and cancer in 2017. [3]
[1] https://www.census.gov/popclock/ [2] https://wwwnc.cdc.gov/eid/article/26/7/20-0282_article [3] https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm
That's because just like in a war, it isn't realistic to expect the frontline soldiers to stay in combat for longer than weeks at a time before they start to exhibit PTSD and their effectiveness begins to drop.
Unless we have large reserves of doctors and nurses to rotate in and out I think we should be very careful not to take them for granted.
The problem is, a vaccine is also a pipe dream. So we're going to have to all get infected over some sort of timeline that doesn't cause societal collapse. Also known as flattening the curve.
To get current infected you then have to multiply it by communication^(days to death), something like 1.1^14, with the first term varying depending on population density and lockdown measures, and the second on how on the ball that locality is for detecting cases and keeping people alive.
Yes. Stanford's recent study says 2-4% of the population of Santa Clara County has been infected. Those are probably reasonable bounds. Herd immunity is around 80% for this. So about 20 to 40 times as many people need to die before it's over.
That test needs to be repeated weekly to get the growth rate. (Preferably not with the scheme from Verity, which requires that you sign up for a Google account.[1]) Now that California hospital admissions and deaths for COVID-19 have flattened, growth should be linear for a while. But the rate of increase is still not really known.
Still, we're probably looking at a year and a million deaths in the US, within a factor of 2 either way.
[1] https://verily.com/stories/the-project-baseline-covid-19-pro...
There is a very major risk with extrapolating the Santa Clara data in the motivation of those being tested has not been controlled. Who is more likely to want to know they have been infected - those who have had classic COVID-19 symptoms or those who haven’t.
Source? Right now, that seems unknown - too soon to tell. A few months of measuring antibody levels and we'll know more.
> our estimates of specificity are 99.5% (95 CI 98.1-99.9%) and 100% (95 CI 90.5-100%)
Look at the those confidence intervals, even the narrower one (from the manufacturer's data)! The bottom is a four-fold increase in false positives, compared to the point-estimate, and is greater than the total positives they had in their finding.
Based on quick amateur reading of the paper, the rate of crude positives (1.5%) might be entirely real cases, entirely false positives, or anywhere in between. The real rate of infection could be anywhere from 0% to 5%.
The authors report around 3,500 real tests and 30 known-negative tests. We need 30,000 real data points (or 300 known-negative tests) to conclude anything. (Right?)
I am not criticizing the experts who conducted the study. Thank you for doing the study. I'm only trying to understand what the study reveals. It may reveal that the group needs 10x more funding right away.
Teasing out data from all that noise requires that the false positive error rate be measured very accurately. And they didn't do that, so really this doesn't tell us much.
Edit: Alternatively, borrowing jargon from a more common field around here: the measured infection rate of ~3% is very close to the noise floor of the experiment. It might be that, or it might be near zero, and we can't tell the difference. This study is very good evidence that the infection fraction is not much larger, however. We can easily rule out high infection rates like the 30% numbers that seems to get thrown around.
But the takeaway should be that this is a good thing. Every unknown case we uncover decreases the overall rate of hospitalization and death, and potentially decreases the effective transmission rate (assuming most people who had the virus develop immunity and that the immunity lasts, which is also still unclear).
And additionally, there are reports of reinfections among covid19 patients who were found to be cured.
Herd immunity. If testing is only detecting 1/50th of cases in NYC, for example, it means that there have been about 6M cases, or about 69% of NYC's population. That's basically the threshold where we'd expect to see the infection counts level off naturally.
"And additionally, there are reports of reinfections among covid19 patients who were found to be cured."
Like I said in my comment, it is still unclear how immunity works.
AFAICT those reports pertain to testing positive again, not to actual reinfection. The leading hypothesis from scientists in the studies I've seen is that the tests are picking up RNA from dead virus, which will neither cause symptoms nor be transmissible to others. I certainly hope that hypothesis turns out to be the correct one, because if not we're in for even more trouble.
If the mortality really is very low, then it should be easy to prove. Just go to NYC, do some random testing, and show us an infection rate that far exceeds the false-positive rate.
Sure as hell isn't random (all pregnant women... so all women for one. All at the same hospital is another).
"Between March 22 and April 4, those hospitals screened 215 pregnant women for SARS-CoV-2 (the virus that causes COVID-19), and 33 women, or 15%, tested positive. Of these who tested positive, 29 women — or nearly 14% — showed no symptoms."
I'm sure we are significantly undercounting cases but I highly doubt we are off by a magnitude of 50x.
Given all the other factors, an order of magnitude or more gap between tests and sick people doesn't seem completely out of the question. I would be curious if there are other models using a different methodology which could help us get a handle on the conditional probability chain leading to tests being done or not on an individual, to see if there is a similar set of conclusions.
NYC has similar demographics (and as bad nursing home hits?) -- 0.14% of the population has died from covid. That puts an upper bound of 26x (and that's if the entire population was infected)
Seems kind of useless unless your control group is a lot larger, and the false positive rate can be shown to be <<1.5%.
How is it representative when it's only Facebook users in this sample?
I mean, no. It's not perfect. It will miss demographics like the elderly with lower social media use, but that group tends to be well-sampled already due to their risk profile. It will probably miss some immigrants too, which seems like a bigger problem.
But really, it's a pandemic. It doesn't care about your socioeconomic status. One of its defining qualities is the extent to which it does not cluster in particular communities like more typical epidemics.
I'm much more concerned about selection bias toward prior sick people; IIRC, Stanford offered to report positive results to the patient.
Without reading the study, though, possible they actually controlled that in the demographic profile for the ad.
Edit:
Going to the other thread confirmed this. From the paper,
"This study had several limitations. First, our sampling strategy selected for members of Santa Clara County with access to Facebook and a car to attend drive-through testing sites. This resulted in an over-representation of white women between the ages of 19 and 64, and an under-representation of Hispanic and Asian populations, relative to our community. Those imbalances were partly addressed by weighting our sample population by zip code, race, and sex to match the county. We did not account for age imbalance in our sample, and could not ascertain representativeness of SARS-CoV-2 antibodies in homeless populations. Other biases, such as bias favoring individuals in good health capable of attending our testing sites, or bias favoring those with prior COVID-like illnesses seeking antibody confirmation are also possible. The overall effect of such biases is hard to ascertain."
> Wuhan’s Zhongnan Hospital found that 2.4% of its employees and 2% to 3% of recent patients and other visitors, including people tested before returning to work, had developed antibodies, according to senior doctors there.
Additional antibody testing is also underway in Wuhan.
Source: https://www.wsj.com/articles/wuhan-starts-testing-to-determi...
Of course that's not the narrative that fits agendas so just like with "why cant we test people?" back then, there will be many official reasons not to look for antibody data and to doubt what data gets gathered.
https://www.cdc.gov/flu/weekly/#S6
Look carefully at the black and red graph after the phrase “mortality surveillance data”.
If you look at the first set of graphs, you'll see a spike around the same time for influenza tests. I don't know how fast pneumonia occurs in people weakened by influenza, but I would expect some delay.
I think the spike in both influenza and in death due to influenza and pneumonia is probably due to testing. If you presented with influenza like symptoms in March, you were definitely given a flu test to rule out influenza.
Anecdotally, I remember in December / January reading about this being the worst flu season in years (time). it would have been interesting to know if the flu was effecting the normal cohort or ignoring children.
I myself got the 2nd worst sick I have ever been at the end of November visiting San Francisco. (really bad dry cough, fever). It was strange in the sense that I had mild symptoms for a bout two weeks and then 'took my breath away'. went to the hospital, no pneumonia, but low oxygen levels. my friends kid got the same thing, mild cough for a few days and fine. didn't really recover until mid January. Was it covid19? probably not, was probably the flu.
That doesn't discount the possibility this was running around the globe even in December. I don't stick my head in the sand and wait for people to tell me so to consider that's at least a very possible scenario.
https://www.cdc.gov/flu/about/burden/preliminary-in-season-e...
Basically, if you're in a suburban area and pick up a few viral particles from one coffee-shop counter, it's possible that you're not in nearly as much danger as someone touching handrails and inhaling subway air all day long.
https://www.journalofinfection.com/article/S0163-4453(20)301...
My optimistic side wants the truth to be that there are many strains, and the worst one spread in the last few months. This would mean that there are other strains that provide adequate anti-bodies and yet are mild enough to go unnoticed by professionals.
http://med.stanford.edu/news/all-news/2020/04/testing-pooled...
> The researchers found that the burden of COVID-19 in the Bay Area prior to mid-February was low. Only two of nearly 3,000 people with respiratory-disease symptoms who were tested in early 2020 at Stanford Health Care or affiliated clinics for common respiratory viruses were infected with SARS-CoV-2, the virus that causes COVID-19.
It seems pretty obvious that we need to do the same experiment on samples from New York, Washington, Michigan, etc.
The raw hospitalization rate is inflated because both treatment and testing are mostly limited to very severe cases in places where there's a lot of confirmed cases (e.g. NYC.)
Iceland PCR data is reliable but it is suggestive of an IFR of more like 0.3%. Except Iceland also managed to successfully isolate their elderly so if you correct for that, we're back at 0.7% or so for the general population.
Deaths in both places can only increase and deaths will inevitably be retroactively assigned a Coronavirus cause.
This is the most poorly-designed serosurvey we've seen yet, frankly. It advertised on Facebook asking for people who wanted antibody testing. This has an enormous potential effect on the sample - I'm so much more likely to take the time to get tested if I think it will benefit me, and It's most likely to benefit me if I'm more likely to have had COVID. An opt-in design with a low response rate has huge potential to bias results.
Sample bias (in the other direction) is the reason that the NIH has not yet released serosurvey results from Washington:
We’re cautious because blood donors are not a representative sample. They are asymptomatic, afebrile people [without a fever]. We have a “healthy donor effect.” The donor-based incidence data could lag behind population incidence by a month or 2 because of this bias.
Presumably, they rightly fear that, with such a high level of uncertainty, bias could lead to bad policy and would negatively impact public health. I'm certain that these data are informing policy decisions at the national level, but they haven't released them out of an abundance of caution. Those conducting this study would have done well to adopt that same caution.
If you read closely on the validation of the test, the study did barely any independent validation to determine specificity/sensitivity - only 30! pre-covid samples tested independently of the manufacturer. Given the performance of other commercial tests and the dependence of specificity on cross-reactivity + antibody prevalence in the population, this strikes me as extremely irresponsible.
This paper elides the fact that other rigorous serosurveys are neither consistent with this level of underascertainment nor the IFR this paper proposes. Many of you are familiar with the Gangelt study, which I have criticized. Nevertheless, it is an order of magnitude more trustworthy than this paper (both insofar as it sampled a larger slice of the population and had a much much higher response rate). It also inferred a much higher fatality rate of 0.37%. IFR will, of course, vary from population to population, and so will ascertainment rate. Nevertheless, the range proposed here strains credibility, considering the study's flaws. 0.13% of NYC's population has already died, and the paths of other countries suggest a slow decline in daily deaths, not a quick one. Considering that herd immunity predicts transmission to stop at 50-70% prevalence, this is baldly inconsistent with this study's findings.
For all of the above reasons, I hope people making personal and public health decisions wait for rigorous results from the NIH and other organizations and understand that skepticism of this result is warranted. I also hope that the media reports responsibly on this study and its limitations and speaks with other experts before doing so.
[1] https://www.reddit.com/r/COVID19/comments/g32wjh/covid19_ant...
The next best alternative is monitoring a large number of people with antibodies (and a control group) for new infections. This is slow and expensive, but if you have enough people then it will work.
> These prevalence estimates represent a range between 48,000 and 81,000 people infected in Santa Clara County by early April, 50-85-fold more than the number of confirmed cases.
However, a caveat is that antibody tests might have high rates of false positives, which would be a particularly large problem when very few people are actually positive. So read this with a grain of salt. The paper isn't peer reviewed yet etc.
It would point out that actual Covid-19 mortality could be close to that of seasonal flu, as it tells us the number of people infected is 50X-85X than the number of confirmed cases.
Assuming the data is reliable, of course.
https://www.nationalreview.com/the-morning-jolt/chinas-devas...
My point was just that with the information we had in December, there was no way politically to enact the extraordinary (and extraordinarily damaging) measures that would have been required to prevent an epidemic.
Not only was it politically untenable (Trump was only acquitted on February 5th!) but it was simply scientifically unsupported and unjustifiable at that time.
IMO even with hindsight being 20/20 I can’t say given the information we had on January 1 that we could or should have done any differently than the travel ban on January 31st, which itself was extraordinary. Everything post January 31st however is an absolute boondoggle of the highest degree.
As far as PPE and testing capacity, I believe those are both systemic issues which needed to be dealt with years ago. Good luck with the US trying to procure a billion masks from China right at the onset of their own health crisis — imagine how that would play out with 1,000s of deaths in Wuhan and 0 known cases in the US. We would have been accused of hoarding and causing the spread in China.
The testing issue was mainly an easily foreseeable and preventable regulatory problem at the FDA which has existed for some time. It took too long to remove the regulatory hurdles, but that there was not already a pandemic regulatory response framework ready to activate is totally inexcusable since we already went through this in 2009.
SARS-2 was circulating outside China in SE Asia before Dec. 15.
BlueDot warned subscribers Dec. 30.
WHO notification was Dec. 31.
Disneyworld Shanghai was closed Jan. 24.
You can't hear anything when you don't listen.
I think not.
The Lancet reported on January 24th the Time of Onset of the earliest known patients in Wuhan in a nice graphic [0]. The first case onset in Wuhan is reported as December 1st.
"Chinese epidemiologists with the Chinese Center for Disease Control and Prevention published an article on 20th January 2020 stating that the first cluster of (~40) patients with ‘pneumonia of an unknown cause’ had been identified on 21st December 2019". [1]
Much later, just in the last few weeks, new reports have come out trying to trace earlier possible cases of COVID. Here is one such case dating back to November 17th, in Hubei [2]. This was not known in December or January.
There is a pre-print available as of April 8th claiming to have found an earlier case through genome tracing dating as early as mid-September in Guangdong, a southern coastal province in China. [3]
> SARS-2 was circulating outside China in SE Asia before Dec. 15.
Citation needed.
My other dates are straight from the National Review, and I believe they are accurate.
The first known case in the US was discovered on January 21st.
Here is WHO writing on January 5, 2020 [4];
"On 31 December 2019, the WHO China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) detected in Wuhan City, Hubei Province of China. As of 3 January 2020, a total of 44 patients with pneumonia of unknown etiology have been reported to WHO by the national authorities in China. Of the 44 cases reported, 11 are severely ill, while the remaining 33 patients are in stable condition. According to media reports, the concerned market in Wuhan was closed on 1 January 2020 for environmental sanitation and disinfection."
I claimed that there was nothing that could have been done by the US in the December time frame, and I believe that is self-evident from the timeline. Looking at that statement from the WHO on January 5th, there is nothing in that which could possibly motivate a national quarantine response at that time. Not even in China, but certainly not in the US.
[0] - https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachme...
Full Text:
(https://www.thelancet.com/journals/lancet/article/PIIS0140-6...)
[1] - https://bfpg.co.uk/2020/04/covid-19-timeline/
[2] - https://www.livescience.com/first-case-coronavirus-found.htm...
[3] - https://www.pnas.org/content/early/2020/04/07/2004999117
[4] - https://www.who.int/csr/don/05-january-2020-pneumonia-of-unk...
Obviously mitigation efforts still play some part in limiting the spread, but I would not bet that all of those communities were able to suppress such a contagious disease before a big chunk of the population was exposed to it.
Here's Germany's imputed CFR: https://spectator.us/covid-antibody-test-german-town-shows-1...
Here's Denmark: https://www.dr.dk/nyheder/indland/doedelighed-skal-formentli...
Here's Iceland: https://reason.com/2020/04/03/what-we-should-have-learned-fr...
More studies coming next week from LA.
As I said, Sweden is in the middle of the pack. Your response is not a rebuttal to that. Lockdown is meant to avoid deaths by ensuring everyone has a bed, which in Sweden they do. Beyond that death rates will diverge for other reasons - it appears Sweden is seeing large racial disparities in deaths for some reason, as is America. So as a country that took in a lot more immigrants than Norway that would by itself be a contributing factor. But deaths due to not getting hospital beds is something we can safely say isn't happening, which means the justification for the lockdown is invalidated.
I'm really uncertain why so many people are resisting this outcome. It's a good one! Lockdowns are bad! If they have no effect then that means they should end and that's great for absolutely everyone.
While these numbers are indicators, they are non-representative samples. Different communities spread the disease to different demographics.
A CFR of 0.4% is still huge, especially if it is very non-uniform and would mean 1.2mio deaths in the US if it saturates.
And if that isnt enough for you, we still don't have reliable information about long term effects of an infection. It could end up being persistent like herpes or HIV, make people sterile or reduce lung capacity and or increase chance of cancer.
With these, possibly small, risks, it is ethically incredibly irresponsible to allow the disease spread through the whole population. You cannot gamble with a conceivable downside like that.
That sequence of words shows you do not know the basics of epidemiology. Epidemics do not affect 100% of a population.
https://www.ecodibergamo.it/stories/valle-brembana/il-grido-...
1) Studies linked above are properly statistically randomized 2) Italy population dead = old smokers, Chinese from Wuhan working in factories
The study is a random population sample. A single tiny town Italy has a highly characterized population. If you disagree, you've never been to Italy.
Stop being scared. Start being logical.
So your suggestion is entirely unworkable unless there is a plan to remove all at-risk persons from contact with low-risk persons.
Please show your work and let us know what that plan looks like. Who will care for these people, how will they be housed, how will you prevent the care force from bringing infection to them ala nursing homes, etc.
And yet anti-science morons in SF clutch their scarf over their mouths when you jog past them.
Of course, the bigger issue is that we can't rule out that the antibody tests have a false positive rate that can explain the whole result. We need serology tests in places with a higher positive rate to know.
Basically, 50 positive results out of 3330 is a really small signal. Just a small false positive rate or sampling issue could explain all the positive results.